Combining Antidepressants for Major Depression Treatment
Author Information
Author(s): Martín-López Luis M., Rojo Jose E., Gibert Karina, Martín Juan Carlos, Sperry Lyli, Duñó Lurdes, Bulbena Antonio, Vallejo Julio
Primary Institution: Institute of Neuropsychiatry and Addictions, Hospital del Mar, Barcelona, Spain
Hypothesis
The study aims to assess the use of antidepressant combinations in Spain.
Conclusion
The prevalence of antidepressant combination therapy is low, with only 2.2% of the global sample using it.
Supporting Evidence
- 27.1% of patients were on antidepressant monotherapy treatment.
- 2.2% of patients were on combination therapy.
- The most frequent combinations were SSRIs and tricyclic antidepressants.
- Fluoxetine was the most widely combined active principle.
- Significant differences were found in episode duration between combination and monotherapy groups.
Takeaway
This study looked at how often doctors in Spain use more than one antidepressant to help people with depression. They found that it's not very common.
Methodology
The study reviewed three databases from naturalistic studies involving 2842 patients diagnosed with major depression.
Limitations
The study did not assess the characteristics of the psychiatrists who prescribed combinations or the dosages of the drugs used.
Participant Demographics
The sample had a mean age of 47.48 years, with 67.5% women and a predominant marital status of married (62.1%).
Statistical Information
P-Value
0.001
Statistical Significance
p=0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website